FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095349447> ?p ?o ?g. }

• W2095349447 endingPage "15" @default.
• W2095349447 startingPage "8" @default.
• W2095349447 abstract "Acta Neurologica ScandinavicaVolume 95, Issue s169 p. 8-15 Viruses and multiple sclerosis A. G. Dalgleish, Corresponding Author A. G. Dalgleish Division of Oncology, Department of Cellular & Molecular Sciences, St George's Hospital Medical School, Jenner Wing, Cranmer Terrace, London SW17 0RE, UKDivision of Oncology, Department of Cellular & Molecular Sciences, St George's Hospital Medical School, Jenner Wing, Cranmer Terrace, London SW17 0RE, UKSearch for more papers by this author A. G. Dalgleish, Corresponding Author A. G. Dalgleish Division of Oncology, Department of Cellular & Molecular Sciences, St George's Hospital Medical School, Jenner Wing, Cranmer Terrace, London SW17 0RE, UKDivision of Oncology, Department of Cellular & Molecular Sciences, St George's Hospital Medical School, Jenner Wing, Cranmer Terrace, London SW17 0RE, UKSearch for more papers by this author First published: 29 January 2009 https://doi.org/10.1111/j.1600-0404.1997.tb08144.xCitations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kurtke JP. MS epidemiology worldwide; one view of current status. Acta Neurol Scand 1995: suppl. 161: 23 – 33. 2 Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection [published erratum appears in Clin Microbiol Rev 1994: 7(1): 141]. Clin Microbiol Rev 1993: 6(4): 382–427. 3 Gerety SJ, Karpus WJ, Cubbon AR et al. Class II-Restricted T Cell Responses in Theiler's Murine Encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994: 152(2): 908 – 918. 4 Bureau JF, Montagutelli X., Bihl F., Lefebvre S., Guenet JL, Brahic M.. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nature Gen 1993: 5(1): 87 – 91. 5 Clatch RJ, Melvold RW, Dal Canto MC, Miller SD, Lipton HL. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. J Neuroimmunol 1987: 15(2): 121 – 135. 5 Correale J., Li S., Weiner LP, Gilmore W.. Effect of persistent mouse hepatitis virus infection on MHC class I expression in murine astrocytes. J Neurosci Res 1995: 40(1): 10 – 21. 6 Crane MA, Yauch R., Dal Canto MC. Kim BS. Effect of immunization with Theiler's virus on the course of demyelinating disease. J Neuroimmunol 1993: 45(1–2): 67 – 73. 7 Dal Canto MC, Melvold RW, Kim BS, Miller SD. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Technique 1995: 32(3): 215 – 229. 8 Liuzzi GM, Riccio P., Dal Canto MC. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice. J Neuroimmunol 1995: 62(1): 91 – 102. 9 Michiels T., Jarousse N., Brahic M.. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 1995: 214(2): 550 – 558. 10 Miller DJ, Rodriguez M.. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination. Microsc Res Technique 1995: 32(3): 230 – 245. 11 Musette P., Bureau JF, Gachelin G., Kourilsky P., Brahic M.. Tlymphocyte repertoire in Theiler's virus encephalomyelitis: the nonspecific infiltration of the central nervous system of infected SJL/J mice is associated with a selective local T cell expansion. Eur J Immunol 1995: 25(6): 1589 – 1593. 12 Nicholson SM, Peterson JD, Miller SD, Wang K., Dal Canto MC, Melvold RW. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 1994: 52(1): 19 – 24, 1994. 13 Oleszak EL, Kuzmak J., Good RA, Platsoucas CD. Immunology of Theiler's murine encephalomyelitis virus infection. Immunol Res 1995: 14(1): 13 – 33. 14 Olsberg C., Pelka A., Miller S. et al. Induction of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Regional Immunol 1993: 5(1): 1 – 10. 15 Pelka A., Olsberg C., Miller S. et al. Effects of irradiation on development of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice. Cell Immunol 1993: 152(2): 440 – 455. 16 Pullen LC, Park SH, Miller SD, Dal Canto MC, Kim BS. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J Immunol 1995: 155(9): 4497 – 503. 17 Rodriguez M., Nabozny GH, Thiemann RL, David CS. Influence of deletion of T cell receptor V beta genes on the Theiler's virus model of multiple sclerosis. Autoimmunity 1994: 19(4): 221 – 230. 18 Rodriguez M., Prayoonwiwat N., Zhou P., David C.. Expression of T cell receptor V beta transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination. J Neuroimmunol 1993: 47(1): 95 – 100. 19 Sierra A., Rubio N.. Theiler's murine encephalomyelitis virus induces tumour necrosis factor-alpha in murine astrocyte cell cultures. Immunology 1993: 78(3): 399 – 404. 20 Yauch RL, Kerekes K., Saujani K., Kim BS. Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice. J Virol 1995: 69(11): 7315 – 7318. 21 Yauch RL, Kim BS. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VPI (233–244). J Immunol 1994: 153(10): 4508 – 4519. 22 Tsunoda I., Fujinami RS. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 1996: 55(6): 673 – 86. 23 Peterson JD, Karpus WJ, Clatch RJ, Miller SD. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 1993: 23(1): 46 – 55. 24 Wang FI, Stohlman SA, Fleming JO. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 1990: 30(1): 31 – 41. 26 Atkins GJ, Sheahan BJ, Mooney DA. Pathogenicity of Semliki forest virus for the rat central nervous system and primary rat neural cell cultures: possible implications for the pathogenesis of multiple sclerosis. Neuropathol App Neurobiol 1990: 16(1): 57 – 68. 27 Tansey EM, Allen TG, Ikeda H.. Enhanced retinal and optic nerve excitability associated with demyelination in mice infected with Semliki forest virus. Brain 1986: 109 (Pt I): 15 – 30. 28 Burnett LA, Whitton JL, Wang LY, Fujinami RS. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J Neuroimmunol 1996: 64(2): 163 – 173. 29 Peasel R., Murphy WH. Co-infection with LDH and C type retrovirus causes neurological disease. Nature 1980: 286: 398 – 400. 30 Rohowsky-Kochan C., Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995: 45(8): 1554 – 1560. 31 Summers BA, Appel MJ. Aspects of canine distemper virus and measles virus encephalomyelitis. Neuropathol App Neurobiol 1994: 20(6): 525 – 534. 32 Kennedy P.. Neurological aspects of lentivirae infection. Ballière's Clin Neurol 1992: 1(1): 41 – 59. 33 Souberbielle BE, Szawlowski PW, Russell WC. Is there a case for a virus aetiology in multiple sclerosis Scot Medl J 1995: 40(2): 55 – 62. 34 Patrick BA, Mehta PD, Sobczyk W. et al. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 1990: 26(1): 69 – 74. 35 Walsh MJ, Shapshak P., Graves MC, Imagawa DT, Tourtellotte WW. Isoelectric point restriction of cerebrospinal fluid and serum IgG antibodies to measles virus polypeptides in multiple sclerosis. J Neuroimmunol 1987: 14(3): 243 – 252. 36 Shirodaria PV, Haire M., Fleming E., Merrett JD, Hawkins SA, Roberts SD. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 1987: 44(12): 1237 – 1241. 37 Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Annal Neurol 1994: 36 (suppl): S25 – 8. 38 de Silva SM, McFarland HF. Multiple sclerosis patients have reduced HLA class II-restricted cytotoxic responses specific for both measles and herpes virus. J Neuroimmunol 1991: 35(1–3): 219 – 226. 39 Dhib-Jalbut S., Lewis K., Bradburn E., McFarlin DE. McFarland HF. Measles virus polypeptide-specific antibody profile in multiple sclerosis. Neurology 1990: 40 (3 Pt 1): 430 – 435. 40 Godec MS, Asher DM, Murray RS et al. Absence of measles, mumps, and rubella viral genomic sequences from multiple sclerosis brain tissue by polymerase chain reaction. Ann Neurol 1992: 32(3): 401 – 404. 41 Greenham LW, Hicks D., Smith S.. Detection of DNA transcripts of measles genes in multiple sclerosis brain tissue by transfection. J Neurol Sci 1988: 85(1): 55 – 65. 42 Bray PF, Culp KW, McFarlin DE, Panitch HS, Torkelson RD, Schlight JP. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 1992: 42(2): 278 – 282. 43 Bray PF, Luka J., Bray PF, Culp KW, Schllght JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992: 42(9): 1798 – 1804. 44 Dernick R., Uhlig H.. From host components of virus particles to anti-myelin human monoclonal antibodies obtained by Epstein-Barr virus transformation of lymphocytes from multiple sclerosis patients. Behring Inst Mitteilungen 1991: (89): 138 – 145. 45 Haahr S., Sommerlund M., Møller-Larsen A., Mogensen S., Andersen HM. Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus Neuroepidemiology 1992: 11(4–6): 299 – 303. 46 Hilton DA, Love S., Fletcher A., Pringle JH. Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation. J NeurolNeurosurg Psychiatry 1994: 57(8): 975 – 976. 47 Martyn CN, Cruddas M., Compston DA. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993: 56(2): 167 – 168. 48 Warner HB, Carp RI. Multiple sclerosis etiology - an Epstein-Barr virus hypothesis. Med Hypotheses 1988: 25(2): 93 – 97. 49 Lindberg C., Andersen O., Vahlne A., Dalton M., Runmarker B.. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991: 10(2): 62 – 65. 50 Craig JC, Haire M., Merrett JD. T-cell-mediated suppression of Epstein-Barr virus-induced B lymphocyte activation in multiple sclerosis. Clin Immunol Immunopathol 1988: 48(3): 253 – 260. 51 Hays P.. Multiple sclerosis and delayed mumps. Acta Neurol Scand 1992: 85(3): 200 – 203. 52 Baringer JR, Pisani P.. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 1994: 36(6): 823 – 839. 53 Challoner PB, Smlth KT, Parker JD et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995: 92(16): 7440 – 7444. 54 Felgenhauer K., Reiber H.. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Invest 1992: 70(1): 28 – 37. 55 Torelli G., Barozzi P., Marasca R., Cocconcelli P., Merelli E.. Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995: 46(3): 178 – 188. 56 MacGregor HS, Latiwonk QI. Complex role of gammaherpesviruses in multiple sclerosis and infectious mononucleosis. Neurol Res 1993: 15(6): 391 – 394. 57 Martin JR, Holt RK, Webster HD. Herpes-simplex-related antigen in human demyelinative disease and encephalitis. Acta Neuropathol 1988: 76(4): 325 – 337. 58 Ross RT, Nicolle LE, Cheang M.. Varicella zoster virus and multiple sclerosis in a Hutterite population. J Clin Epidemiol 1995: 48(11): 1319 – 1324. 59 McHatters GR, Scham RG. Bird viruses in multiple sclerosis: combination of viruses or Marek's alone Neurosc Lett 1995: 188(2): 75 – 76. 60 Goswami KK, Randall RE, Lange LS, Russell WC. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients. Nature 1987: 327(6119): 244 – 247. 61 Boerman RH, Bax JJ, Beekhuis-Brussee JA, Medaer R., Bollen LE. JC virus and multiple sclerosis: a refutation Acta Neurol Scand 1993: 87(5): 353 – 355. 62 Clausen J., Hoff-Jorgensen R., Rasmussen HB. Antibody reactivity against animal retroviruses in multiple sclerosis. Acta Neurol Scand 1990: 81(3): 223 – 228. 63 Cruickshank K., Rudge P.. Dalgleish AG et al. Tropical spastic paraparesis and HTLV-1 in the United Kingdom. Brain 1989: 112: 1057 – 1090. 64 Dalgleish AG. The immunology of retroviruses. Balliere's Clin Neurol 1992: 1(1): 23 – 40. 65 Richardson JH, Wucherpfennig KW, Endo N., Rudge P., Dalgleish AG, Hafler DA. PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-1, Science 1989: 246: 821 – 823. 66 Perron H., Geny C.. Laurent A. et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989: 140(6): 551 – 561. 67 Perron H., Geny C., Genoulaz O., Pellat J., Ferret J., Seigneurin JM. Antibody to reverse transcriptase of human retroviruses in multiple sclerosis. Acta Neurol Scand 1991: 84(6): 507 – 513. 68 Perron H., Gratacap B., Lalande B. et al. In vitvo transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Res Virol 1992: 143(5): 337 – 350. 69 Perron H., Suh M., Lalande B. et al. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 1993: 74 (Pt 1): 65 – 72. 70 Haahr S., Sommerlund M., Møller-Larsen A.. Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiology. Neuroepidemiology 1991: 10(5–6): 232 – 235. 71 Haahr S., Sommerlund M., Møller-Larsen A., Nielsen R.. Hansen HJ. Just another dubious virus in cells from a patient with multiple sclerosis Lancet 1991: 337(8745): 863 – 864. 72 Haahr S., Sommerlund M., Christensen T., Jensen AW, Hansen HJ, Møller-Larsen A.. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann N Y Acad Sc 1994: 724: 148 – 156. 73 Lan XY, Zeng Y., Zhang D. et al. Establishment of a human malignant T lymphoma cell line carrying retrovirus-like particles with RT activity. Biomed Environ Sci 1994: 7(1): 1 – 12. 74 Rasmussen HB, Clausen J.. Search for a retrovirus in multiple sclerosis by enzymatic amplification of DNA from brain capillaries, brain tissue and mononuclear cells from peripheral blood. Acta Neurol Scand 1992: 86(1): 87 – 90. 75 Coffin J.. In: R. Weiss, N. Teich, H. Varmus, J. Coffin, eds. RNA tumor viruses. Cold Spring Harbour , NY Cold Spring Harbor Laboratory Press 1982: 1: 1109 – 1203. 76 Lower R., Lower J., Kurth R.. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci 1996: 93 (11): 5177 – 5184. 77 Dupressoir A., Heidmann T.. Germ line-specific expression in intracisternal A-particle retrotransposons in transgenic mice. Mol Cell Biol 1996: 16(8): 4495 – 4503. 78 Li MD, Lemke TD, Bronson DL, Faras AJ. Synthesis and analysis of a 640-bp pol region of novel human endogenous retroviral sequences and their evolutionary relationships. Virology 1996: 217(1): 1 – 10. 79 Mager DL, Freeman JD. HERV-H endogenous retroviruses: presence in the New World branch but amplification in the Old World primate lineage. Virology 1995: 213(2): 395 – 404. 80 Zhu ZB, Jian B., Volanakis JE. Ancestry of SINE-R.C2 a human-specific retroposon. Hum Genet 1994: 93(5): 545 – 551. 81 Kellher CA, Wilkinson D., Freeman J.. Mager DL, Gelford EW. Expression of a novel transposon containing mRNA's in human cells. J Gen Virol 1990: 77(5): 1101 – 1110. 82 Brodsky I., Foley B., Gillespie D.. Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukaemia. Leukaemia Lymphoma 1993: 11(1): 119 – 123. 83 Sjottem E., Anderssen S., Johansen T.. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J Virol 1996: 70(1): 188 – 198. 84 Kitamura Y., Ayukawa T., Ishikawa T., Kanda T., Yoshiike K.. Human endogenous retrovirus K10 encodes a functional integrase. J Virol 1996: 70(5): 3302 – 3306. 85 Natoli F., Crowley MR, Asch HL, Stoler DL, Asch BB. Mutations involving the endogenous ecotropic murine leukaemia virus in primary mammary carcinomas of BALB/c mice. Cancer Lett 1996: 99(1): 121 – 127. 86 Kawamoto S., Hashizume S., Katakura Y., Tachibaba H., Murakami H.. Molecular cloning of yeast cytochrome c-like polypeptide expressed in human lung carcinoma: an antigen recognisable by lung cancer-specific human monoclonal antibody In Vitvo. Cell Dev Biol Animal 1995: 31(9): 724 – 729. 87 Kitamura M., Maruyama N., Shirasawa T. et al. Expression of an endogenous retroviral gene product in human placenta. Int J Cancer 1994: 58(6): 836 – 840. 88 Tsumura H., Wang JZ, Ogawa S. et al. The character of endogenous retrovirus in pancreatic beta-cells of NOD mice. Lab Animal Sci 1994: 44(1): 47 – 51. 89 Mitreiter K., Schmidt J., Luz A. et al. Disruption of the murine p53 gene by insertion of an endogenous retrovirus-like element (Etn) in a cell line from radiation-induced osteosarcoma. Virology 1994: 200(2): 837 – 841. 90 Asch BB, Asch HL, Stoler DL, Anderson GR. De-regulation of endogenous retrotransposons in mouse mammary carcinomas of diverse aetiologies. Int J Cancer 1993: 54(5): 813 – 819. 91 Ono M., Yasunaga T., Miyata T., Ushikubo H.. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumour virus genome. J Virol 1986: 60(2): 589 – 598. 92 Ono M., Kawakami M., Ushikubo H.. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell cline T47D. J Virol 1987: 61(6): 2059 – 2062. 93 Kreig AM, Gourley MF, Perl A.. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992: 6(8): 2537 – 2544. 94 Perl A., Banki K.. Human endogenous retroviral elements and autoimmunity: data and concepts. Trends Microbiol 1993: 1(4): 153 – 156. 95 Haahr S., Sommerlund M., Christensen T., Jensen AW, Hansen HJ, Møller-Larsen A.. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann N Y Acad Sci 1994: 724: 148 – 156. 96 Meese E., Gottert E., Zang KD, Sauter M., Schommer S., Mueller-Lantzsch N.. Human endogenous retroviral element k10 (HERV-K10): chromosomal localisation by somatic hybrid mapping and fluorescence in situ hybridisation. Cytogenet Cell Genet 1996: 72(1): 40 – 42. 97 Dalgleish AG, Fazakerley J., Webb H.. Do HTLV-I and similar viruses induce autoimmunity in multiple sclerosis. J Neuropath Appl Neurobiol 1987: 13: 241 – 250. 98 Baum H., Davies H., Peakman M.. Molecular mimicry in the MHC: hidden clues to autoimmunity Immunol today 1996: 17(2): 64 – 70. Citing Literature Volume95, Issues169February 1997Pages 8-15 ReferencesRelatedInformation" @default.
• W2095349447 created "2016-06-24" @default.
• W2095349447 creator A5084290990 @default.
• W2095349447 date "1997-02-01" @default.
• W2095349447 modified "2023-09-27" @default.
• W2095349447 title "Viruses and multiple sclerosis" @default.
• W2095349447 cites W1501676794 @default.
• W2095349447 cites W1514509695 @default.
• W2095349447 cites W1539776265 @default.
• W2095349447 cites W1767157475 @default.
• W2095349447 cites W1967664057 @default.
• W2095349447 cites W1972485557 @default.
• W2095349447 cites W1976492123 @default.
• W2095349447 cites W1980478348 @default.
• W2095349447 cites W1985436072 @default.
• W2095349447 cites W1985667676 @default.
• W2095349447 cites W1986754512 @default.
• W2095349447 cites W1987395473 @default.
• W2095349447 cites W1988017946 @default.
• W2095349447 cites W1989848277 @default.
• W2095349447 cites W1992405381 @default.
• W2095349447 cites W1992498711 @default.
• W2095349447 cites W1998542947 @default.
• W2095349447 cites W1999581382 @default.
• W2095349447 cites W2000189755 @default.
• W2095349447 cites W2000304086 @default.
• W2095349447 cites W2005717677 @default.
• W2095349447 cites W2010808384 @default.
• W2095349447 cites W2014179331 @default.
• W2095349447 cites W2016039266 @default.
• W2095349447 cites W2017670652 @default.
• W2095349447 cites W2018106089 @default.
• W2095349447 cites W2018826999 @default.
• W2095349447 cites W2019262750 @default.
• W2095349447 cites W2019850761 @default.
• W2095349447 cites W2019955807 @default.
• W2095349447 cites W2022106044 @default.
• W2095349447 cites W2022505144 @default.
• W2095349447 cites W2026005120 @default.
• W2095349447 cites W2027838150 @default.
• W2095349447 cites W2029396088 @default.
• W2095349447 cites W2032676970 @default.
• W2095349447 cites W2040632916 @default.
• W2095349447 cites W2042843827 @default.
• W2095349447 cites W2047816556 @default.
• W2095349447 cites W2048038708 @default.
• W2095349447 cites W2050727112 @default.
• W2095349447 cites W2054410263 @default.
• W2095349447 cites W2055110728 @default.
• W2095349447 cites W2055649014 @default.
• W2095349447 cites W2055859925 @default.
• W2095349447 cites W2056295878 @default.
• W2095349447 cites W2056638076 @default.
• W2095349447 cites W2057284222 @default.
• W2095349447 cites W2058239331 @default.
• W2095349447 cites W2059862913 @default.
• W2095349447 cites W2061675263 @default.
• W2095349447 cites W2061690707 @default.
• W2095349447 cites W2062599309 @default.
• W2095349447 cites W2063978201 @default.
• W2095349447 cites W2072356365 @default.
• W2095349447 cites W2073715892 @default.
• W2095349447 cites W2074860813 @default.
• W2095349447 cites W2075261810 @default.
• W2095349447 cites W2078155115 @default.
• W2095349447 cites W2078430746 @default.
• W2095349447 cites W2081239384 @default.
• W2095349447 cites W2081421817 @default.
• W2095349447 cites W2081527865 @default.
• W2095349447 cites W2087748010 @default.
• W2095349447 cites W2089447330 @default.
• W2095349447 cites W2091611912 @default.
• W2095349447 cites W2093942918 @default.
• W2095349447 cites W2099529189 @default.
• W2095349447 cites W2101172185 @default.
• W2095349447 cites W2108447651 @default.
• W2095349447 cites W2111569895 @default.
• W2095349447 cites W2113956933 @default.
• W2095349447 cites W2115396398 @default.
• W2095349447 cites W2136802283 @default.
• W2095349447 cites W2149235949 @default.
• W2095349447 cites W2154121432 @default.
• W2095349447 cites W2155411646 @default.
• W2095349447 cites W2158361859 @default.
• W2095349447 cites W2170328270 @default.
• W2095349447 cites W2171582546 @default.
• W2095349447 cites W2413966579 @default.
• W2095349447 cites W2443647620 @default.
• W2095349447 cites W4241072696 @default.
• W2095349447 cites W1974840742 @default.
• W2095349447 cites W2044745869 @default.
• W2095349447 cites W2072484454 @default.
• W2095349447 doi "https://doi.org/10.1111/j.1600-0404.1997.tb08144.x" @default.
• W2095349447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9174635" @default.
• W2095349447 hasPublicationYear "1997" @default.
• W2095349447 type Work @default.
• W2095349447 sameAs 2095349447 @default.
• W2095349447 citedByCount "47" @default.

• next